
Drug control department Tamil Nadu announced on Monday the cancellation of the production license Sresan Pharmaceutical Company, a syrup producer Cough, who was associated with the death of at least 22 people in Madhya Pradesh. The state government confirmed that the company was permanently closed after an investigation that revealed toxic contaminants, namely diethylene glycol (DEG), in its syrup.
What measures did the TN government take?
The State Health Department has ordered comprehensive inspections across all pharmaceutical manufacturing units in Tamil Nadu, with extensive inspections are currently underway. Two older drug inspectors were also suspended because of leaving the duty.
The court in Parasia sent the owner of Sresan Pharma Ranganathan to the 10 -day police custody after his arrest 9 October in Chennai by a special investigative team (SIT) of Madhya Pradesh.
What critics did the political leaders express?
The BJP leader criticized the government of Tamil over the treatment of the case and accused her of creating a “illusion” and avoiding responsibility.
“The drug produced by a private pharmaceutical company in Kanchipuram reportedly caused the death of 23 people in Madhya Pradesh and three children in Rajasthan. However, the Tamil government suspended only two drug inspectors and attempts to create an illusion on this matter,” Annamalai said.
He also stressed that society had the history of quality violations and that Drug Inspectors Tamil Nadu could not carry out proper checks.
“Yesterday, Drug CEO in India (DCGI) decided. This time the agency decided that every drug produced in India must undergo compulsory testing before approval,” Annamalai added.
What steps does DCGI take?
After the incident, a general controller issued a directive in India (DCGI) for all countries and trade unions and called for strict drug and cosmetic rules from 1945 from 1945 to test raw materials and finished pharmaceutical formulations.
What does it mean for public security?
The aim of the closure of Sresan Pharma and ongoing inspections is to prevent similar tragedies and ensure better responsibility in the Indian pharmaceutical industry. The authorities emphasize that strict adherence to test standards and regulatory supervision is now decisive for public health protection.
(Tagstotranslate) production license